General

About Company
Haematologic Technologies produces coagulation proteins, antibodies, and factor deficient plasmas for research.

Industry

Sector :

Subsector :

founded date

01.01.1987

Company Type

For Profit

IPO status

Private

Description

With over 30 years of experience in protein chemistry, Prolytix (formerly Haematologic Technologies) offers research and development services, characterization by high-resolution mass spectrometry, GxP testing, and custom collection devices to clients worldwide. They use an agile, consultative approach to support product development from discovery through GMP release, providing proven CMC and regulatory expertise. Prolytix is the go-to partner for protein therapeutic projects, offering accessible, attentive, and seasoned teams for routine to complex projects. To learn more, visit GoProlytix.com.
Contacts